WPRIM Management System> DCMS> Chinese Journal of Cardiology> 2006> 34> 6

Volume: 34 Issue: 6

1. The molecular mechanisms of apolipoprotein B mediating the atherogenic lipoprotein metabolism. Page:571—573
2. Endocannabinoid system and metabolic syndrome. Page:568—570
3. Glycolytic and fatty acid metabolic enzyme changes early after acute myocardial ischemia. Page:546—550
4. Angiotensin II induced cardiac hypertrophy is blocked by PTEN via suppressing Ca2+/Calcineurin pathway. Page:541—545
5. Effect of serum autoantibodies against the M2 muscarinic acetylcholine receptors from patients with heart failure on L-Type Ca2+ channel activity in guinea pig cardiac myocytes. Page:537—540
6. Bezafibrate up-regulate endothelial nitric oxide gene expressions via peroxisome proliferator-activated receptors alpha-dependent and independent pathways in cultured Bovine endothelial cells. Page:530—536
7. Electrophysiological characterization of long QT syndrome associated mutations V630A and N633S. Page:523—527
8. Interleukin-6-597G/A and -572C/G polymorphisms and risk of coronary heart disease. Page:519—522
9. The relationship between oxidized form glutathione, coenzyme II and carotid artery atherosclerosis. Page:515—518
10. The role of atherosclerotic plaque stability and inflammation in the pathogenesis of acute coronary syndrome. Page:512—514
11. Chronic effects of spironolactone in conjunction with an angiotensin-converting enzyme inhibitor enalapril on circulating procollagen marker P III NP and vascular resistance in patients with essential hypertension. Page:508—511
12. Prediction value for operative mortality of four different coronary artery bypass graft risk stratification models in Chinese patients. Page:504—507
13. Magnetocardiography changes in coronary artery disease patients with normal or unspecialized resting electrocardiogram. Page:500—503
14. Effects of transcatheter closure in children with congenital coronary artery fistula. Page:492—494
15. Compare drug-eluting stent to bare-metal stent in prognosis on treating diffuse coronary lesions. Page:487—491
16. Post primary percutaneous coronary intervention no-reflow in patients with acute myocardial infarction: contributing factors and long-term prognostic impact. Page:483—486
17. Today's percutaneous coronary intervention is a state-of-the-art strategy for acute coronary syndrome. Page:481—482